Nktx stock forecast.

Cell therapy developer Nkarta, Inc. ( NASDAQ: NKTX) fell ~34% on Tuesday as Wall Street reacted to updated data from its Phase 1 trial for lead candidate NKX101 in patients with relapsed or ...Written by Zacks Equity Research for Zacks ->. Nkarta, Inc. NKTX announced that the FDA has cleared the investigational new drug (IND) application to move its investigational candidate, NKX019 ...US$296.82m. Market Cap. US$128.57m. NKTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. n/a. Enterprise Value/EBITDA.On August 10, 2023, Nkarta, a company listed on NASDAQ under the ticker symbol NKTX, revealed its financial performance for Nkartas Financial Report Highlights Strong Liquidity and Positive Outlook - Best StocksDec 2, 2023 · The consensus price target of analysts on Wall Street is $14.13, which implies an increase of 80.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $25.00 respectively. As a result, NKTX is trading at a discount of -819.12% off the target high and -230.88% off the low.

$ 1.898326 1-Month Prediction $ 1.713021 3-Month Prediction Unlock 6-Month Prediction Unlock 1-Year Prediction Unlock Loading... According to our current NKTX stock …Find the latest dividend history for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.

Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00....

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Seven Arts Entertainment share forecasts, stock quote and buy / sell signals below. According to present data Seven Arts Entertainment's SAPX shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ... The Nkarta stock forecast for tomorrow is $ 1.934144, which would represent a 1.73% gain compared to the current price. In the next week, the price of NKTX is expected to decrease by -0.16% and hit $ 1.898326. As far as the long-term Nkarta stock forecast is concerned, here’s what our ...2.64 +0.15 (6.02%) Nov 30, 2023, 4:00 PM EST - Market closed Financials Forecast Profile Forecast Analyst Ratings Nkarta Stock Forecast All Analysts Top Analysts Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%.1.43. -0.05. -3.72%. Get Nkarta Inc (NKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Nkarta Stock (NASDAQ:NKTX), Analyst Ratings, Price Targets, Predictions benzinga.com - September 9 at 6:21 PM: Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Ventyx Biosciences (VTYX) markets.businessinsider.com - August 14 at 6:19 PM: Mizuho Maintains Nkarta (NKTX) Buy Recommendation nasdaq.com - August 14 at 6:19 PM

Nkarta Inc, with its stock symbol NKTX, operates from the USA and made its public debut on July 10, 2020. The company is at the forefront of developing engineered natural killer (NK) cells for cancer treatment. ... The stock's performance and valuation metrics indicate a cautious outlook for potential investors. Comparative Analysis with ...

Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...The Nkarta Inc. stock price gained 1.16% on the last trading day (Friday, 24th Nov 2023), rising from $2.59 to $2.62. During the last trading day the stock fluctuated 3.53% from a day low at $2.55 to a day high of $2.64. The price has risen in 6 of the last 10 days and is up by 27.8% over the past 2 weeks. Volume fell on the last day by -163 ...June 28, 2023 at 6:35 AM · 2 min read. Nkarta, Inc. (NKTX) has been beaten down lately with too much selling pressure. While the stock has lost 39.3% over the past four weeks, there is light at ...Acumen Pharmaceuticals Inc. 2.37. +0.01. +0.42%. Get Nkarta Inc (NKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Jun 2, 2023 · Analyst Price Forecast Suggests 852.85% Upside As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60.

Since the start of the year, NKTX lost 77% of its equity value. However, in sharp contrast to the market performance, analysts rate NKTX a unanimous strong buy. Their average price target lands at ...Vertex Energy Stock Forecast, VTNR stock price prediction. The best long-term & short-term Vertex Energy share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 ...Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile. ... Positive Outlook for Nkarta's Stocks: Key Developments and Future Expectations in NK Cell Therapy.2023-01-17. 3,691. $5.49. $20.26k Sell. 1 of 2. NKTX insiders have sold more... subscribe to Premium to read more. Net Insider Buy/Sell (L12M) Ownership. Be the first to know when NKTX insiders and whales buy or sell their stock. Get Free NKTX Updates.What is Nkarta's Market Cap? ( NASDAQ: NKTX) Nkarta 's market cap is $127.10M, as of Nov 24, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Nkarta 's market cap is calculated by multiplying NKTX 's current stock price of $2.59 by NKTX 's total outstanding shares of.Oct. 17, 2023, 07:24 AM. (RTTNews) - Biopharmaceutical company Nkarta, Inc. (NKTX) announced Tuesday the clearance of an Investigational New Drug (IND) application by the U.S. Food and Drug ...

About the Nkarta, Inc. stock forecast. As of 2023 October 17, Tuesday current price of NKTX stock is 1.495$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

2.64 +0.15 (6.02%) Nov 30, 2023, 4:00 PM EST - Market closed Financials Forecast Profile Forecast Analyst Ratings Nkarta Stock Forecast All Analysts Top Analysts Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%.Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12-month price targets for Nkarta. The company has an ...Find the latest Quoin Pharmaceuticals, Ltd. (QNRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Complete Nkarta Inc. stock information by Barron's. View real-time NKTX stock price and news, along with industry-best analysis.Nkarta is an oncology company that uses the innate capacities of natural killer cells to target tumors. Its current market cap is around 620 million. The below shows a chart of its share price ...Technology Services. Industry. Packaged Software. No executives to display. Corporate headquarters. San Jose, California. Find real-time NTNX - Nutanix Inc stock quotes, company profile, news and ...

The average Livent stock price prediction forecasts a potential upside of 45.25% from the current LTHM share price of $14.32. What is LTHM's forecast return on equity ...

Find real-time TMPO - Tempo Automation Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...0 Oppenheimer Downgrades Nkarta to Perform Best Analysts Covering Nkarta Most Accurate Analysts Most Profitable Analysts Which Analyst Should I Follow If I Want to …Overview News Ideas Financials Technicals Forecast NKTX chart Today 1.22% 5 days −1.58% 1 month 19.71% 6 months −46.79% Year to date −58.84% 1 year −69.41% 5 …The two key market catalysts that have moved stock prices in the past two years will remain front and center in November: inflation and interest rates. The consumer price index gained 3.7% year ...Nov 15, 2023 · Analysts are generally bullish on Nkarta’s long-term prospects, but they are divided on how high the stock price could go in 2023. Some analysts believe that the stock could reach $20 or even $30 per share, while others believe that it is more likely to trade in the $10-$15 range. Ultimately, how high NKTX will go in 2023 is a matter of ... Find real-time NXPI - NXP Semiconductors NV stock quotes, company profile, news and forecasts from CNN Business.Stock analysis for Nkarta Inc (NKTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the ...Nextracker last posted its quarterly earnings data on October 25th, 2023. The reported $0.55 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.25. The firm had revenue of $573.36 million for the quarter, compared to the consensus estimate of $547.24 million. Nextracker has generated $0.00 earnings per share over the …Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should Know Zacks - Tue Jun 7, 8:55AM CDT . The consensus price target hints at a 209.4% upside potential for Nkarta, Inc. (NKTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...Nkarta ( NASDAQ: NKTX) is a company that allogeneically harnesses the power of natural killer cells or NK cells against cancer. The company is in early stages, with two phase 1 programs, and a ...

Chief Financial & Business Officer exercised options and sold US$71k worth of stock Jul 28. Nkarta, Inc. Announces Executive Changes Jul 26. Price target decreased to US$43.56 Jul 18. ... NKTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: NKTX is forecast to have no revenue next year.28 thg 6, 2023 ... ... stocks growth stocks (according to analyst forecasts). Have feedback on this article? Concerned about the content? Get in touch with us ...Nkarta, Inc. (NKTX) share price prediction for 2023, 2024, 2025, 2026 and 2027. NKTX one year forecast. Nkarta stock monthly and weekly forecasts.Instagram:https://instagram. trusted online gold dealersin cold blood robert blaketicker symbol onyseamerican slnd Get the latest Nkarta Inc (NKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.$ 1.898326 1-Month Prediction $ 1.713021 3-Month Prediction Unlock 6-Month Prediction Unlock 1-Year Prediction Unlock Loading... According to our current NKTX stock … ripple labs stocktexas capital bancshares inc Find real-time LTHM - Livent Corp stock quotes, company profile, news and forecasts from CNN Business.Currently, Nkarta Inc [NKTX] is trading at $2.61, up 10.83%. An important factor to consider is whether the stock is rising or falling in short-term value. The NKTX shares have gain 28.57% over the last week, with a monthly amount glided 10.59%, and seem to be holding up well over a long-time horizon. On 9, online brokerage compare Nkarta's earnings are forecast to decline at 9.2% per annum while its annual revenue is expected to grow at 77.8% per year. EPS is expected to grow by 7.3% per annum.Nkarta (NKTX) is a clinical-stage biopharmaceutical company that develops and commercializes cell therapies for cancer treatment. The company's co-lead product candidates are NKX101 and NKX019, which are in phase I trials for various B cell malignancies. Analysts have a consensus rating of Buy and a price target of $15.67, up 671.8% from its current price of $2.03.